Amorfix Life Sciences Ltd. Announces Breakthrough Scientific Discovery and Provides Update for Its Ovarian Cancer Therapeutic Antibody Program
4/9/2013 10:39:00 AM
More...
|
Amorfix Life Sciences Ltd. Acquires SOD1 Technology and Provides Update on Financing
3/12/2012 9:49:09 AM
More...
|
Amorfix Life Sciences Ltd. Licenses ALS Antibodies To Biogen Idec, Inc. (Massachusetts) (BIIB); Amorfix To Receive $1 Million Upfront
7/15/2010 7:37:21 AM
More...
|
Amorfix Life Sciences Ltd. Announces Dr. George Adams to Step Down from President & CEO
6/2/2010 6:29:52 AM
More...
|
Amorfix Life Sciences Ltd. Launches Alzheimer's Amyloid Test at Scientific Conference in Vienna
7/15/2009 7:05:13 AM
More...
|
Amorfix Life Sciences Ltd. Expands Diagnostic and Therapeutic Focus to Include Misfolded Protein Diseases Including Cancer
4/20/2009 6:40:46 AM
More...
|
Amorfix Life Sciences Ltd. Receives Third Biogen Idec, Inc. (Massachusetts) (BIIB) Investment
11/17/2008 11:42:19 AM
More...
|
Amorfix Life Sciences Ltd. Announces Fiscal 2009 Second Quarter Results
11/7/2008 4:16:34 PM
More...
|
Amorfix Life Sciences Ltd. Sheep Scrapie Results from Blinded Panels Presented at International Prion Conference
10/9/2008 4:42:54 PM
More...
|
Amorfix Life Sciences Ltd. Sets Up vCJD Blood Screening Assay in UK and Begins to Test Blood Donor Samples
9/23/2008 3:13:32 PM
More...
|
|